95
Participants
Start Date
December 13, 2018
Primary Completion Date
July 1, 2019
Study Completion Date
August 7, 2019
Sm14
Three 0.5 mL intra-muscular injections of the vaccine solution (50μg Sm14) will be administered on D0, W4, W8 (D = day, W = week).
GLA-SE solution
The lot concentration 10μg/mL for injection of 2.5μg GLA-SE/injection.
Biomedical Research Center EPLS, Saint-Louis
Collaborators (2)
Orygen Biotecnologia SA
UNKNOWN
Biomedical Research Center EPLS
OTHER
Access to Advanced Health Institute (AAHI)
OTHER
Oswaldo Cruz Foundation
OTHER